معرفی
Dr. Christopher Choy is a Research Fellow in the Department of Drug Discovery Biology at Monash University. His research focuses on neuropharmacology, schizophrenia, and muscarinic receptor modulation, with contributions to understanding learning/memory mechanisms and neurodevelopmental trajectories. He leads the 2023-2026 project 'Modulation of the M4 muscarinic receptor for the treatment of schizophrenia,' serving as a Chief Investigator. Choy’s work spans drug discovery, receptor signaling, and neurodevelopmental disorders, with over 20 peer-reviewed publications since 2008. His research integrates behavioral neuroscience with molecular pharmacology to address neurological and psychiatric conditions.
Key areas of expertise include muscarinic acetylcholine receptor modulation, neuroinflammation mechanisms, and the impact of viral infections on neurodevelopmental outcomes. He collaborates internationally on projects involving peptide therapeutics, allosteric modulator design, and neurodevelopmental modeling in rodents. Choy’s studies frequently utilize mouse models to investigate cognitive deficits and receptor pharmacology, contributing to translational medicine for schizophrenia and Alzheimer’s disease.
Recent work highlights advancements in understanding influenza A virus’s effects on offspring neurodevelopment and the development of novel M1/M4 muscarinic receptor modulators. His research aligns with Sustainable Development Goals related to health and well-being (SDG 3), emphasizing disease prevention and innovative therapeutic strategies.
